AI is driving unprecedented investment for massive data centers and an energy supply that can support its huge computational appetite. One potential source of electricity for these facilities is next-generation nuclear power plants, which could be cheaper to construct and safer to operate than their predecessors. We recently held a subscriber-exclusive Roundtables discussion on hyperscale AI data centers and next-gen nuclear --two featured technologies on the MIT Technology Review 10 Breakthrough Technologies of 2026 list . You can watch the conversation back here, and don't forget to subscribe to make sure you catch future discussions as they happen. Demis Hassabis, CEO of Google DeepMind, summed it up in three words: "This is embarrassing." Hassabis was replying on X to an overexcited post by Sébastien Bubeck, a research scientist at the rival firm OpenAI, announcing that two mathematicians had used OpenAI's latest large language model, GPT-5, to find solutions to 10 unsolved problems in mathematics.

Science Corporation, founded by former Neuralink president Max Hodak, has unveiled a prototype machine to extend the life of organs for longer periods. Science Corporation, the brain-computer interface startup founded in 2021 by former Neuralink president Max Hodak, is launching a new division of the company with the goal of extending the life of human organs. Alameda, California-based Science is aiming to improve on current perfusion systems that continuously circulate blood through vital organs when they can no longer function on their own. The technology is used to preserve organs for transplant and as a life-support measure for patients when the heart and lungs stop working, but it's clunky and costly. Science wants to make a smaller, more portable system that could provide long-term support.

Surgeons at Rambam Eye Institute restored sight to a legally blind patient using the world's first 3D printed corneal implant grown from cultured human cells.

Breast MRI provides high-resolution imaging critical for breast cancer screening and preoperative staging. However, existing segmentation methods for breast MRI remain limited in scope, often focusing on only a few anatomical structures, such as fibroglandular tissue or tumors, and do not cover the full range of tissues seen in scans. This narrows their utility for quantitative analysis. In this study, we present BreastSegNet, a multi-label segmentation algorithm for breast MRI that covers nine anatomical labels: fibroglandular tissue (FGT), vessel, muscle, bone, lesion, lymph node, heart, liver, and implant. We manually annotated a large set of 1123 MRI slices capturing these structures with detailed review and correction from an expert radiologist. Additionally, we benchmark nine segmentation models, including U-Net, SwinUNet, UNet++, SAM, MedSAM, and nnU-Net with multiple ResNet-based encoders. Among them, nnU-Net ResEncM achieves the highest average Dice scores of 0.694 across all labels. It performs especially well on heart, liver, muscle, FGT, and bone, with Dice scores exceeding 0.73, and approaching 0.90 for heart and liver. All model code and weights are publicly available, and we plan to release the data at a later date.

Sensory neuroprostheses are emerging as a promising technology to restore lost sensory function or augment human capabilities.

For years, plastic surgeons thought the proportions of a beautiful buttocks should follow the Fibonacci sequence. Now, people are looking for a more Kardashian shape. In the history of gluteal enhancement, Mexico City stands out. It was here, in 1979, that a plastic surgeon, Mario González-Ulloa, first installed a pair of silicone implants designed specifically for the buttocks. The textbook calls González-Ulloa the "grandfather of buttock augmentation." The early 2000s saw a new generation of Mexico City buttock transformation luminaries, notably Ramón Cuenca-Guerra. Cuenca-Guerra laid out four characteristics that "determine attractive buttocks" as well as the five types of "defects," with strategies for correcting each one. I, for instance, have defect type 5, the "senile buttock." While I understand the value of standardizing procedures and setting guidelines for surgical practice, I tripped over Cuenca-Guerra's methodology. How and by whom had the determinants been determined?

The wireless neural transmitter safely delivers brain signals like a microchip. Breakthroughs, discoveries, and DIY tips sent every weekday. Today's neural implants are smaller than ever, but often remain cumbersome and prone to complications . According to researchers at Cornell University, a new iteration detailed this week in the journal may offer a novel path forward for brain implants. Small enough to fit on a grain of rice, the microscale optoelectronic tetherless electrode (or MOTE) is vastly smaller than similar implants and its design could be adapted to work in other delicate areas of the body.

The PRIMA brain computer interface retinal implant helped 80% of patients with advanced age-related macular degeneration regain central vision in a new study.

Competition to deploy commercial brain-computer interfaces is heating up. A microelectronic chip placed under the retina can produce vision. Science Corporation--a competitor to Neuralink founded by the former president of Elon Musk's brain-interface venture--has leapfrogged its rival after acquiring, at a fire-sale price, a vision implant that's in advanced testing,. The implant produces a form of "artificial vision" that lets some patients read text and do crosswords, according to a report published in the today . The implant is a microelectronic chip placed under the retina. Using signals from a camera mounted on a pair of glasses, the chip emits bursts of electricity in order to bypass photoreceptor cells damaged by macular degeneration, the leading cause of vision loss in elderly people.

California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant. The trials will be conducted with a modified version of the Apple Vision Pro headset. Startup Cognixion announced today that it is launching a clinical trial of its wearable brain-computer interface technology integrated with the Apple Vision Pro to help paralyzed people with speech disorders communicate with their thoughts. Cognixion is one of several companies, including Elon Musk's Neuralink, that is developing a brain-computer interface, or BCI, a system that captures brain signals and translates them into commands to control external devices. While Neuralink and others are working on implants that are surgically placed in the head, Cognixion's technology is noninvasive.